Development of MK-4827: A novel oral poly(ADP-ribose)polymerase (PARP) inhibitor efficacious in BRCA-1 and-2 mutant tumors

被引：0
|
作者：
Jones, Philip [1 ]
Altamura, Sergio [1 ]
Boueres, Julia [1 ]
Ferrigno, Federica [1 ]
Fonsi, Massimiliano [1 ]
Gavory, Gerald [1 ]
Giomini, Claudia [1 ]
Koch, Uwe [1 ]
Lamartina, Stefania [1 ]
Monteagudo, Edith [1 ]
Ontoria, Jesus M. [1 ]
Roscilli, Giuseppe [1 ]
Rowley, Michael [1 ]
Scarpelli, Rita [1 ]
Schultz-Fademrecht, Carsten [1 ]
Toniatti, Carlo [1 ]
机构：
[1] IRBM Merck Res Labs Rome, I-00040 Pomezia, Italy
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2009年 / 238卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
220-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase I trial of veliparib, an inhibitor of poly(ADP-ribose) polymerase (PARP), and topotecan (TPT) in patients with solid tumors.
    Hendrickson, Andrea Elisabeth Wahner
    Menefee, Michael E.
    Hartmann, Lynn C.
    Long, Harry J.
    Northfelt, Donald W.
    Reid, Joel M.
    Boakye-Agyeman, Fleix
    Flatten, Karen S.
    Poirier, Guy G.
    Lensing, Janet
    Erlichman, Charles
    Kaufmann, Scott H.
    Haluska, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Radiosensitization with an inhibitor of poly(ADP-ribose) glycohydrolase: A comparison with the PARP1/2/3 inhibitor olaparib
    Gravells, Polly
    Neale, James
    Grant, Emma
    Nathubhai, Amit
    Smith, Kate M.
    James, Dominic I.
    Bryant, Helen E.
    DNA REPAIR, 2018, 61 : 25 - 36
  • [43] Synthesis and SAR of novel tricyclic quinoxalinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)
    Miyashiro, Julie
    Woods, Keith W.
    Park, Chang H.
    Liu, Xuesong
    Shi, Yan
    Johnson, Eric F.
    Bouska, Jennifer J.
    Olson, Amanda M.
    Luo, Yan
    Fry, Elizabeth H.
    Giranda, Vincent L.
    Penning, Thomas D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (15) : 4050 - 4054
  • [44] Combining 53BP1 with BRCA1 as a biomarker to predict the sensitivity of poly(ADP-ribose) polymerase (PARP) inhibitors
    Zhong-min Yang
    Xue-mei Liao
    Yi Chen
    Yan-yan Shen
    Xin-ying Yang
    Yi Su
    Yi-ming Sun
    Ying-lei Gao
    Jian Ding
    Ao Zhang
    Jin-xue He
    Ze-hong Miao
    Acta Pharmacologica Sinica, 2017, 38 : 1038 - 1047
  • [45] Combining 53BP1 with BRCA1 as a biomarker to predict the sensitivity of poly(ADP-ribose) polymerase (PARP) inhibitors
    Yang, Zhong-min
    Liao, Xue-mei
    Chen, Yi
    Shen, Yan-yan
    Yang, Xin-ying
    Su, Yi
    Sun, Yi-ming
    Gao, Ying-lei
    Ding, Jian
    Zhang, Ao
    He, Jin-xue
    Miao, Ze-hong
    ACTA PHARMACOLOGICA SINICA, 2017, 38 (07) : 1038 - 1047
  • [46] Inhibitory polimerazy poli(ADP-rybozy) (PARP) w terapii nowotworow z mutacjami BRCA1/2 Poly(ADP-ribose) polymerase (PARP) inhibitors in BRCA1/2 cancer therapy
    Kluzek, Katarzyna
    Bialkowska, Aneta
    Koczorowska, Aleksandra
    Zdzienicka, Malgorzata Z.
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2012, 66 : 372 - 384
  • [47] Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
    Tutt, Andrew
    Robson, Mark
    Garber, Judy E.
    Domchek, Susan M.
    Audeh, M. William
    Weitzel, Jeffrey N.
    Friedlander, Michael
    Arun, Banu
    Loman, Niklas
    Schmutzler, Rita K.
    Wardley, Andrew
    Mitchell, Gillian
    Earl, Helena
    Wickens, Mark
    Carmichael, James
    LANCET, 2010, 376 (9737): : 235 - 244
  • [48] Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
    Audeh, M. William
    Carmichael, James
    Penson, Richard T.
    Friedlander, Michael
    Powell, Bethan
    Bell-McGuinn, Katherine M.
    Scott, Clare
    Weitzel, Jeffrey N.
    Oaknin, Ana
    Loman, Niklas
    Lu, Karen
    Schmutzler, Rita K.
    Matulonis, Ursula
    Wickens, Mark
    Tutt, Andrew
    LANCET, 2010, 376 (9737): : 245 - 251
  • [49] Nicotinamide, a Poly [ADP-Ribose] Polymerase 1 (PARP-1) Inhibitor, as an Adjunctive Therapy for the Treatment of Alzheimer's Disease
    Salech, Felipe
    Ponce, Daniela P.
    Paula-Lima, Andrea C.
    SanMartin, Carol D.
    Behrens, Maria I.
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [50] Discovery of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor clinical candidate CEP-9722
    Hudkins, Robert L.
    Zulli, Allison L.
    Diebold, James L.
    Wells, Greg
    Aimone, Lisa D.
    Husten, Jean
    Miknyoczki, Sheila
    Ruggeri, Bruce A.
    Ator, Mark A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
12345